Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aravive (ARAV)
NASDAQ:ARAV
Holding ARAV?
Track your performance easily
ARAV Stock Chart & Stats
Day’s Range$0.04 - $0.05
52-Week Range― - ―
Previous Close$0.05
Volume4.04M
Average Volume (3M)N/A
Market Cap
$2.95M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aravive News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ARAV FAQ
What was Aravive’s price range in the past 12 months?
Currently, no data Available
What is Aravive’s market cap?
Currently, no data Available
When is Aravive’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aravive’s earnings last quarter?
Currently, no data Available
Is Aravive overvalued?
According to Wall Street analysts Aravive’s price is currently Overvalued.
Does Aravive pay dividends?
Aravive does not currently pay dividends.
What is Aravive’s EPS estimate?
Aravive’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aravive have?
Currently, no data Available
What happened to Aravive’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aravive?
Among the largest hedge funds holding Aravive’s share is Baker Bros Advisors LP. It holds Aravive’s shares valued at N/A.
---
Aravive Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ARAV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 4.2M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.60%
12-Months-Change
Fundamentals
Return on Equity
-475.98%
Trailing 12-Months
Asset Growth
-69.09%
Trailing 12-Months
Company Description
Aravive
Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
---
ARAV Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ARAV
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-97.80%
reiterated a buy rating 2 years ago
Copying Thomas Shrader's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -97.80% per trade.
---